Profectus BioSciences Receives $9.5 Million Department of Defense Funding to Manufacture Trivalent VesiculoVax™-Vectored Vaccine to Protect Against all Ebola and Marburg Viruses
BALTIMORE, Md., Oct. 31, 2014 /PRNewswire/ — Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the treatment and prevention of infectious diseases, announced today that the Department of Defense (DoD) through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program (MCS-JVAP), a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.
In addition, the USACC has contracted for clinical evaluation of the VesiculoVax™ Zaire-Ebola virus vaccine to meet the current outbreak in West Africa.
......snip....
In July 2014, Profectus BioSciences and the GNL were awarded a 3 year $8.5M grant from the DOD/JVAP to support development of a lyophilized trivalent VesiculoVax™-vectored vaccine to protect against all major strains of Ebola and Marburg viruses delivered as aerosols.
The lyophilized trivalent vaccine is being tested in both pre-exposure and post-exposure studies to confirm protection of non-human primates from aerosol exposure to Ebola and Marburg viruses.
UN Ebola victim being treated in France
The victim has been placed in isolation under high security in an army training hospital in Saint-Mande near Paris
PARIS, France – France is treating a United Nations employee who contracted Ebola in Sierra Leone, the health ministry said on Sunday, November 2.
“This person, who worked in Sierra Leone in the fight against Ebola, has undergone a secure medical evacuation by specialized aircraft,” the ministry said in a statement.
The victim has been placed in isolation under high security in an army training hospital in Saint-Mande near Paris.
A French nurse, who worked for Doctors Without Borders (MSF) in Liberia, was treated for Ebola at the same hospital in September and recovered.
Despite around 500 reports of possible Ebola infections in France since June, not one has so far tested positive, the ministry added.
France has 12 research hospitals ready to take in suspected Ebola cases.
The Ebola epidemic had killed at least 4,922 people out of 13,703 cases up to October 27, almost all in the west African countries of Liberia, Sierra Leone and Guinea, according to the latest World Health Organization figures.
http://www.rappler.com/world/regions/europe/73781-un-ebola-victim-france